Steroids stories breaking when no other news is going on means that everyone is gonna get out in front of it. Like, way in front of it. This stuff with Ryan Braun went down on Saturday and I think people have already decided what his grandchildren’s legacy is going to be as a result.
But not so fast, says the MLBA! Its head honcho Michael Weiner released a statement this morning telling everyone to chill out:
“Our Joint Drug Agreement is designed to protect a player from a rush to judgment before he can challenge a reported positive test result. Fairness dictates that Ryan Braun be treated no differently. I urge all to reserve judgment on this matter until the JDA’s process has played itself out.”
He’s right. Good luck with that because the mob is already mobbing, but he’s right.
Rangers GM Jon Daniels said he doesn’t expect the club to make a $17.9 million qualifying offer to free agent third baseman Adrián Beltré, MLB.com’s T.R. Sullivan reports. Daniels has been in touch with the 39-year-old, who may retire.
Beltré battled hip and hamstring issues throughout the past season, limiting him to 119 games. He hit .273/.328/.434 with 15 home runs and 65 RBI in 481 plate appearances. Going by adjusted OPS, his mark of 98 — 100 is average — was his lowest in a season since 2009 with the Mariners. Beltré’s career average is 116 and he put up a 132 in 2017 and 128 in ’16.
Beltré appears to have some stuff left in the tank. He may not be an All-Star-caliber player anymore, but he can still hit at an average level and he is still an above-average defender. It’s just a matter of his body holding up to allow him to do what he needs to do. If Beltré does decide to re-up with the Rangers for 2019, the club will be prepared to move Isiah Kiner-Falefa or Jurickson Profar over to the hot corner as they did in 2018 in the event Beltré gets bitten by the injury bug.